PROKIDNEY CORP.
- CIK: 0001850270
- EIN: 98-1586514
- Business address: 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM, North Carolina, 27103
Information
Mailing address
3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM, Cayman Islands, 27103Phone
336-999-7029State location
North CarolinaState of incorporation
Cayman IslandsFiscal year end
December 31SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)Filings
N/A
About PROKIDNEY CORP.
PROKIDNEY CORP. (CIK: 0001850270) is an American company incorporated in the state of North Carolina. Head office is located at 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM, North Carolina, 27103. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). PROKIDNEY CORP. is a public company and trade via Over-The-Counter (OTC).Old names:
- Social Capital Suvretta Holdings Corp. III from 2021-21-Apr to 2022-11-Jul
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| SC PIPE Holdings LLC | 0001938696 | Oct-05-2023 | 10 percent owner |
| Palihapitiya Chamath | 0001715450 | Sep-19-2023 | 10 percent owner |
| SC Master Holdings, LLC | 0001851024 | Sep-19-2023 | 10 percent owner |
| Culleton Bruce | 0001983742 | Jul-17-2023 | officer: EVP, Clinical Development |
| Cowen Aaron | 0001869640 | Mar-31-2023 | 10 percent owner |
| Weger Mary | 0001638460 | Dec-01-2022 | officer: Chief People Officer |
| MARAGANORE JOHN | 0001180432 | Jul-11-2022 | director |
| DOYLE WILLIAM F | 0001194459 | Jul-11-2022 | director |
| Control Empresarial de Capitales S.A. de C.V. | 0001273693 | Jul-11-2022 | 10 percent owner |
| Pereira Brian JG | 0001298146 | Jul-11-2022 | director |
| Lotvin Alan | 0001472795 | Jul-11-2022 | director |
| Bertram Timothy | 0001488033 | Jul-11-2022 | director, officer: Chief Executive Officer |
| Legorreta Pablo G. | 0001507678 | Jul-11-2022 | director, 10 percent owner |
| Sinha Uma | 0001742587 | Jul-11-2022 | director |
| Fox Jennifer A. | 0001841557 | Jul-11-2022 | director |
| Girolamo Todd C | 0001891257 | Jul-11-2022 | officer: Chief Legal Officer |
| Coulston James | 0001936203 | Jul-11-2022 | officer: Chief Financial Officer |
| McKenzie Libbie Parker | 0001936222 | Jul-11-2022 | officer: Chief Medical Officer |
| Weber Darin J. | 0001936228 | Jul-11-2022 | officer: SVP of Regulatory Development |
| Jain Deepak | 0001936247 | Jul-11-2022 | officer: Chief Operating Officer |
| Jimenez Santos Jose Ignacio | 0001937007 | Jul-11-2022 | director |
| Tolerantia, LLC | 0001937011 | Jul-11-2022 | 10 percent owner |
| Semigran Marc | 0001691494 | Jun-29-2021 | director |
| Ryans James | 0001724596 | Jun-29-2021 | officer: Chief Financial Officer |
| SCS Sponsor III LLC | 0001850379 | Jun-29-2021 | director, 10 percent owner |
| Mehta Kishan | 0001850520 | Jun-29-2021 | other: Manager |
| Katz Shoney | 0001854438 | Jun-29-2021 | officer: Director of Research |
| ChaChaCha DNA III, LLC | 0001869713 | Jun-29-2021 | other: Majority Owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PROKIDNEY CORP.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-015495 ( Act) Size: 0 KB |
Feb-06-2025 | |
| SCHEDULE 13D/A | Document | Acc-no: 0001011438-25-000080 (34 Act) Size: KB | Feb-06-2025 | 25597977 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-015369 ( Act) Size: 0 KB |
Feb-06-2025 | |
| 8-K | Document | Current report filing Acc-no: 0000950170-25-007217 (34 Act) Size: KB |
Jan-21-2025 | 25542519 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-130207 (34 Act) Size: KB |
Nov-22-2024 | 241489820 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-125312 (34 Act) Size: KB |
Nov-12-2024 | 241447844 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-124585 (34 Act) Size: KB |
Nov-12-2024 | 241443347 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0002012383-24-003655 (34 Act) Size: KB |
Nov-08-2024 | 241439785 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000895421-24-000594 (34 Act) Size: KB |
Nov-08-2024 | 241438398 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000899140-24-001094 (34 Act) Size: KB |
Oct-22-2024 | 241386227 |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000899140-24-001093 ( Act) Size: 0 KB |
Oct-22-2024 | |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0002012383-24-000636 (34 Act) Size: KB |
Oct-18-2024 | 241380600 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-108438 ( Act) Size: 0 KB |
Sep-20-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-007271 (33 Act) Size: 0 KB |
Sep-19-2024 | 241310709 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-106912 ( Act) Size: 0 KB |
Sep-16-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-103630 ( Act) Size: 0 KB |
Sep-04-2024 | |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-102554 (34 Act) Size: KB |
Sep-03-2024 | 241271921 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-094732 (34 Act) Size: KB |
Aug-09-2024 | 241192501 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-094341 (34 Act) Size: KB |
Aug-09-2024 | 241190391 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-089935 ( Act) Size: 0 KB |
Aug-02-2024 |
Recent 20 filings. View all PROKIDNEY CORP. filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Catherine
Thanks I look forward to using the product to improve my skin tone
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Frequently Asked Questions
Tags:
- PROKIDNEY CORP. overview
- PROKIDNEY CORP. job
- PROKIDNEY CORP. stock
- PROKIDNEY CORP. ownership
- PROKIDNEY CORP. CEO
- PROKIDNEY CORP. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 